Optimize informed consent forms to help accelerate study start-up times

How streamlining informed consent form generation can eliminate weeks from clinical trial start-up Every drug that makes it to the clinical trial stage requires a variety of informed consent forms (ICF) for study participants. These forms are highly scrutinized by the study’s institutional review board (IRB) and/or ethics committee to ensure the information is clear, understandable, and free of attempts to coerce or influence the participant. The information included on the forms simply must be correct.   The traditional process for creating these informed consent forms requires many time-consuming manual steps by a wide variety of people. Content must be